Animal models of Parkinson's disease: vertebrate genetics
about
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkinTherapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and OptogeneticsMitochondrial biogenesis and dynamics in the developing and diseased heartCRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseasesVPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's DiseaseParthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss.Topographic organization of the human and non-human primate subthalamic nucleus.Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyDifferential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsGenetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivoVPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function.Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in miceActivation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegenerationAdult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons.Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein PathologyProgressive degeneration of dopaminergic neurons through TRP channel-induced cell death.New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's diseaseHarnessing the power of yeast to unravel the molecular basis of neurodegeneration.Large Animal Models of Huntington's Disease.Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator.Parkin-dependent mitophagy in the heart.Central Parkin: The evolving role of Parkin in the heart.Retrograde Axonal Degeneration in Parkinson Disease.Conserved regulators of cognitive aging: From worms to humans.Early Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease.Neurodegenerative Disease Transmission and Transgenesis in Mice.Models of LRRK2-Associated Parkinson's Disease.Beyond Mitophagy: The Diversity and Complexity of Parkin Function.E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation.ATP-sensitive potassium channels: uncovering novel targets for treating depression.New developments in genetic rat models of Parkinson's disease.Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin.CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease
P2860
Q24298771-B3AEF8A0-38D6-455C-8EF6-F3B3CEBA6325Q26765373-FD283789-1316-4A92-A3A0-B0A81BF2FC65Q26782031-45EAB004-90F6-4E2A-A2C1-318F3A565736Q26799640-86339356-CF5A-4308-B71F-2A3A3ED30EB9Q28116122-F44F3FFD-B7CF-40CA-8981-DBE468169BC8Q30547326-6362449A-33AC-4020-A22D-33EB1F438DA0Q30940309-3BDA7B16-A986-4FF1-9649-983AE051D10AQ33603777-35637D74-3247-4B34-A487-7CEBD9A2DE42Q33825413-D194755E-9AC2-448F-A86C-4F2CC1904BE4Q35912064-7757CA68-165C-45B3-8D61-C013ED0F0434Q36048102-2A73C2AB-824F-4139-897E-86D574719D5FQ36561435-BC73B73B-BF66-475D-AD17-3DFE626367E3Q37137895-862EA252-C2AB-41F3-A0E9-3585F896E6D4Q37232753-F78111C6-39D3-4FF1-A61D-DAF30158A5D0Q37707932-A63356DC-AB67-4ECE-BAB3-92C643FF7360Q37717607-3432FB81-5E74-49BC-9B17-8110C6A580C2Q38075712-7F97FE77-50AA-404A-BD42-4150643289F2Q38100231-8CA0AC99-1096-4E2C-B21F-F687C4E41D5AQ38139322-4F772FB2-01B1-4D93-A73B-44443326FF53Q38355004-0565BC7B-8DFE-43E6-9345-2A2F4F574886Q38649668-C45A01BA-1B9C-4F5F-9B98-77E902748542Q38780774-C575C078-7CB3-4D01-B259-7CDCBB4A0454Q38785075-57AF99A9-E3A8-4F9B-B75C-6AF8A71121C1Q38872413-F922C36E-8A26-4017-854C-E0C15A10B172Q39075710-F0EF5370-2E7C-4832-ACBE-5CBFFDFA3CA1Q39134078-F1C5BEBF-4A04-42CF-8FBE-68710242C5E6Q39206443-489072EC-3086-43BE-8E29-81CDEF38E238Q44935739-E71C8421-5C2F-4AB3-B60D-1FA7574EFA4DQ46308077-EA987259-AF59-4F51-A7B1-A12F5B9E88BFQ47147264-71226975-790F-4075-B8A9-372ECE817583Q48075452-07CD5BC3-7CC5-414E-8305-0A44898D68C9Q48502440-C20AFEE7-264B-49DC-8D16-1CD7739D7BBDQ50199812-1BC57734-3985-460C-A0A7-E540C6375556Q54453237-D12F5784-477D-4918-8AC9-B8E999360AC0Q58765503-F7FB3628-7629-467C-861A-1C0B9DD1071C
P2860
Animal models of Parkinson's disease: vertebrate genetics
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Animal models of Parkinson's disease: vertebrate genetics
@ast
Animal models of Parkinson's disease: vertebrate genetics
@en
type
label
Animal models of Parkinson's disease: vertebrate genetics
@ast
Animal models of Parkinson's disease: vertebrate genetics
@en
prefLabel
Animal models of Parkinson's disease: vertebrate genetics
@ast
Animal models of Parkinson's disease: vertebrate genetics
@en
P2860
P1476
Animal models of Parkinson's disease: vertebrate genetics
@en
P2093
Valina L Dawson
P2860
P356
10.1101/CSHPERSPECT.A009324
P577
2012-10-01T00:00:00Z